CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Increase (Decrease) in Other Operating Assets
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Increase (Decrease) in Other Operating Assets of $6.21 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2017-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets for the quarter ending 2016-12-31 was $513.00K, a 93.12% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets for the quarter ending 2016-09-24 was $2.20M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets for the quarter ending 2016-06-25 was $70.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets for the quarter ending 2016-03-26 was $3.43M, a 37.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets for fiscal 2016 was $6.21M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets for fiscal 2015 was -$850.00K, a 116.52% decline from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets for fiscal 2014 was $5.14M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. increase (decrease) in other operating assets for fiscal 2013 was -$2.42M, a 2169.23% decline from fiscal 2012.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 6 month as first filed | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2016-12-31 | $513.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $2.71M derived: sum of 2 quarters · filed 2017-02-14 | $2.78M derived: sum of 3 quarters · filed 2017-02-14 | $6.21M 10-K · filed 2017-02-14 | |||
| 2016-09-24 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $2.27M derived: sum of 2 quarters · filed 2016-11-02 | $5.70M 10-Q · filed 2016-11-02 | $13.16M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2016-06-25 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $3.50M 10-Q · filed 2016-08-03 | $10.96M derived: sum of 3 quarters · filed 2017-02-14 | $8.52M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2016-03-26 | $3.43M 10-Q · filed 2016-05-04 | $10.89M derived: sum of 2 quarters · filed 2017-02-14 | $8.45M derived: sum of 3 quarters · filed 2017-02-14 | -$2.87M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-12-26 | $7.46M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $5.02M derived: sum of 2 quarters · filed 2017-02-14 | -$6.30M derived: sum of 3 quarters · filed 2017-02-14 | -$850.00K 10-K · filed 2017-02-14 | |||
| 2015-09-26 | -$2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$13.76M derived: sum of 2 quarters · filed 2016-11-02 | -$8.31M 10-Q · filed 2016-11-02 | -$18.22M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-27 | -$11.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$5.87M 10-Q · filed 2016-08-03 | -$15.78M derived: sum of 3 quarters · filed 2017-02-14 | -$15.65M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-28 | $5.45M 10-Q · filed 2016-05-04 | -$4.46M derived: sum of 2 quarters · filed 2017-02-14 | -$4.33M derived: sum of 3 quarters · filed 2017-02-14 | $4.60M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-27 | -$9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$9.78M derived: sum of 2 quarters · filed 2017-02-14 | -$846.00K derived: sum of 3 quarters · filed 2017-02-14 | $5.14M 10-K · filed 2017-02-14 | |||
| 2014-09-27 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $9.06M derived: sum of 2 quarters · filed 2015-11-04 | $15.05M 10-Q · filed 2015-11-04 | $4.72M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-28 | $8.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $14.93M 10-Q · filed 2015-07-30 | $4.59M derived: sum of 3 quarters · filed 2016-02-12 | $8.19M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-29 | $5.99M 10-Q · filed 2015-04-30 | -$4.35M derived: sum of 2 quarters · filed 2016-02-12 | -$743.00K derived: sum of 3 quarters · filed 2016-02-12 | -$1.21M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-28 | -$10.34M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$6.73M derived: sum of 2 quarters · filed 2016-02-12 | -$7.20M derived: sum of 3 quarters · filed 2016-02-12 | -$2.42M 10-K · filed 2016-02-12 | |||
| 2013-09-28 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $3.14M derived: sum of 2 quarters · filed 2014-10-30 | $7.92M 10-Q · filed 2014-10-30 | $9.23M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2013-06-29 | -$462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $4.31M 10-Q · filed 2014-08-07 | $5.62M 10-Q · filed 2013-07-31 | $5.63M derived: sum of 3 quarters · filed 2015-02-17 | $1.76M derived: sum of 4 quarters · filed 2015-02-17 | ||
| 2013-03-30 | $4.78M 10-Q · filed 2014-04-30 | $6.09M derived: sum of 2 quarters · filed 2015-02-17 | $2.23M derived: sum of 3 quarters · filed 2015-02-17 | $4.43M derived: sum of 4 quarters · filed 2015-02-17 | |||
| 2012-12-29 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$2.55M derived: sum of 2 quarters · filed 2015-02-17 | -$345.00K derived: sum of 3 quarters · filed 2015-02-17 | $117.00K 10-K · filed 2015-02-17 | $296.00K 10-K · filed 2013-02-27 | ||
| 2012-09-29 | -$3.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$1.66M derived: sum of 2 quarters · filed 2013-10-30 | -$1.20M 10-Q · filed 2013-10-30 | $898.00K derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $2.67M 10-Q · filed 2013-07-31 | $4.76M derived: sum of 3 quarters · filed 2014-02-25 | $3.69M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | $462.00K 10-Q · filed 2013-05-08 | $2.56M derived: sum of 2 quarters · filed 2014-02-25 | $1.49M derived: sum of 3 quarters · filed 2014-02-25 | $321.00K derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.02M derived: sum of 2 quarters · filed 2014-02-25 | -$141.00K derived: sum of 3 quarters · filed 2014-02-25 | $265.00K 10-K · filed 2014-02-25 | -$505.00K 10-K · filed 2012-02-27 | ||
| 2011-09-24 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$2.24M derived: sum of 2 quarters · filed 2012-11-01 | -$1.83M 10-Q · filed 2012-11-01 | -$7.23M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-25 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$759.00K 10-Q · filed 2012-08-07 | -$6.15M derived: sum of 3 quarters · filed 2013-02-27 | -$2.82M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-26 | $406.00K 10-Q · filed 2012-05-04 | -$4.99M derived: sum of 2 quarters · filed 2013-02-27 | -$1.66M derived: sum of 3 quarters · filed 2013-02-27 | -$1.85M derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-25 | -$5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$2.06M derived: sum of 2 quarters · filed 2013-02-27 | -$2.25M derived: sum of 3 quarters · filed 2013-02-27 | $2.13M 10-K · filed 2013-02-27 | |||
| 2010-09-25 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $3.14M derived: sum of 2 quarters · filed 2011-11-02 | $7.52M 10-Q · filed 2011-11-02 | $7.30M 10-Q · filed 2010-11-04 | $211.00K derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-06-26 | -$188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | $4.20M 10-Q · filed 2011-08-03 | $4.16M 10-Q · filed 2010-08-03 | -$3.12M derived: sum of 3 quarters · filed 2012-02-27 | -$885.00K derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-03-27 | $4.38M 10-Q · filed 2011-05-04 | -$2.93M derived: sum of 2 quarters · filed 2012-02-27 | -$697.00K derived: sum of 3 quarters · filed 2012-02-27 | ||||
| 2009-12-26 | -$7.31M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$5.08M derived: sum of 2 quarters · filed 2012-02-27 | -$1.46M 10-K · filed 2012-02-27 | ||||
| 2009-09-26 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $5.85M 10-Q · filed 2010-11-04 | |||||
| 2009-06-27 | $3.62M 10-Q · filed 2010-08-03 | ||||||
| 2008-12-27 | -$6.21M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |